CVS Health's operating cash flow stood at USD 7,119 mil in 2Q2020, up 33.4% when compared to the previous year. Historically, between 1Q2010 - 2Q2020, the firm’s operating cash flow reached a high of USD 7,119 mil in 2Q2020 and a low of USD -136 mil in 4Q2017.
CVS Health's total investments stood at USD -1,333 mil and accounted for 0.686% of sales in 2Q2020. This is compared to an average of 1.13% as seen over the last five years.
Cash from financing amounted to USD -978 mil, so the company generated USD 4,808 mil net cash in 2Q2020.
At the end of 2Q2020, the company had a net debt of USD 74,586 mil, or 3.77x of EBITDA and 109% of equity. Net working capital amounted to USD 21,758 mil, or 33.3% of sales. Cash conversion cycle is negative and reached 29.9 days days in 2Q2020. This means CVS Health generates revenue from customers before it has to pay its suppliers for inventory, among other things.
You can see all the company’s data at CVS Health profile, or you can download a report on the company in the report section.
Helgi Library 
